AVT02 (adalimumab biosimilar)
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
biosimilar |
| gptkbp:ATCCode |
L04AB04
|
| gptkbp:biosimilar |
gptkb:adalimumab
|
| gptkbp:brand |
gptkb:Simlandi
Hukyndra |
| gptkbp:developer |
gptkb:Alvotech
|
| https://www.w3.org/2000/01/rdf-schema#label |
AVT02 (adalimumab biosimilar)
|
| gptkbp:indication |
gptkb:Crohn's_disease
gptkb:psoriatic_arthritis ulcerative colitis rheumatoid arthritis ankylosing spondylitis plaque psoriasis hidradenitis suppurativa |
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:status |
approved in US
approved in EU |
| gptkbp:bfsParent |
gptkb:Alvotech
|
| gptkbp:bfsLayer |
8
|